Research conducted by scientists from the University of British Columbia has discovered evidence that men who have used psychedelic substances in the past have decreased chances of being involved with violence against their partners. In the study, which was reported in the “Journal of Psychopharmacology,” the scientists note that their findings do not apply to women.
The study’s lead author, Michelle Thiessen, who also happens to be a clinical psychology graduate student from the institution’s Okanagan campus, stated that the researchers’ focus was on the link between violence and psychedelic substances. She explained that while the link between violence and substance use had been studied, studies on the association between violence and psychedelics were scarce. Thiessen added that the researchers also wanted to learn whether psychedelic substances were linked to violence in the same way that cocaine, alcohol and other substances are. She also observed that the team also wanted to delve deeper into this link to find out whether there were any possible mechanisms underlying this association.
For their study, the scientists focused on emotion regulation and conducted a survey that involved more than 1,200 individuals who had been recruited through social media and from universities.The researchers found that in comparison with men with no history of psychedelic use, those who had consumed psilocybin mushrooms or LSD in their lifetime were less likely to perpetrate violence against an intimate partner.
In an interview, Thiessen explained that generally, classic psychedelic substances didn’t appear to carry the same risk of domestic violence associated with some other substances, which are legal, such as alcohol. Additionally, she continued, men who had consumed psychedelic substances also had less difficulty with negative emotions, which partly explained why they took part in less violence. On the other hand, those who did perpetrate intimate partner violence demonstrated larger difficulties with emotion regulation.
Thiessen noted that the study had some limitations, among them the fact that all the information used in the study was collected at one point in time, which made it possible that men who had fewer issues with negative emotions were more inclined to consume psychedelics and take part in less violence.
A lot of studies on the use of psychedelic substances in the medical setting were carried out from the ‘50s through the ‘70s. However, the banning of these substances made it harder for more research to be conducted.
The recent psychedelic renaissance has, however, prompted research on these products to begin once more, with researchers striving to learn more about these substances with great potential, for which little is currently known.
These studies highlighting the positive behavioral effects of psychedelics are likely to embolden entities such as Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF), which is engaged in developing psychedelic medicines aimed at addressing some of the most drug-resistant mental health conditions.
NOTE TO INVESTORS: The latest news and updates relating to Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) available in the company’s newsroom at https://ibn.fm/TRYPF
About PsychedelicNewsWire
PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.
To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.PsychedelicNewsWire.com
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer
Do you have questions or are you interested in working with PNW? Ask our Editor
PsychedelicNewsWire (PNW)
San Francisco, California
www.PsychedelicNewsWire.com
415.949.5050 Office
Editor@PsychedelicWire.com
PsychedelicNewsWire is part of the InvestorBrandNetwork.